Abselion raises £6.6 million led by M Ventures to bring disruptive at-line protein analyser, Amperia, to market
December 4, 2024
December 4, 2024
December 3, 2024
September 26, 2024
September 24, 2024
May 15, 2024
May 14, 2024
May 8, 2024
May 6, 2024
February 21, 2024
December 16, 2024
BetaGlue® Therapeutics S.p.A. (“BetaGlue”) an Italian clinical-stage oncology company developing an innovative radiotherapy platform for the targeted ...
December 11, 2024
The Institute of Tissue Medicine of the University of Bern Chooses Indica Labs’ HALO AP® to Become the First Public Health Institute in Switzerland to...
December 10, 2024
Innovative Cell Expansion System Enables Real-Time Metabolic Monitoring and Automated Culture Optimization to Accelerate Cell and Gene Therapy Manufac...
Life Science Newswire is a division of BioStrata Ltd, with company registered address: 3rd Floor, 1 Ashley Road, Altrincham, Cheshire, England, WA14 2DT. Company registration number: 8233225